ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of TA-65, a Telomerase Activator on Metabolic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02531334
Recruitment Status : Active, not recruiting
First Posted : August 24, 2015
Last Update Posted : February 8, 2018
Sponsor:
Information provided by (Responsible Party):
Maria Luz Fernandez, University of Connecticut